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ABSTRACT
Background  There is sufficient evidence to show the 
mortality reduction effect of colorectal cancer (CRC) 
screening programs using the fecal occult blood test 
(FOBT). However, we see cases  that are  found  to be 
advanced CRC despite yearly FOBT screening.
Methods  The aim of this study was to investigate the 
characteristics of advanced CRC detected by a fecal 
immunochemical test (FIT) screening program in par-
ticipants with a negative  screening  result  the previous 
year, which we call “Negative advanced CRC”. A total 
of 109,639 participants (10.0% required colonoscopy, of 
whom 76.9% received one) underwent a CRC screening 
program using a FIT from fiscal 2009 to 2017. Negative 
advanced CRC was compared with advanced CRC (First 
advanced CRC) found at the first visit in a person who 
had not had a FIT  screening history  for more  than 3 
years.  In addition, we compared  the characteristics of 
Negative advanced CRC with  those of  interval cancer: 
cancer cases detected after a negative screening result 
and before the date of the next recommended screening.
Results  A  total of 339 cases of CRC  (175 male: 164 
female, 173 early  stage: 166 advanced stage) were de-
tected in the nine-year CRC screening period. The rate 
of right-sided CRCs was significantly higher  in female 
(P < 0.01),  advanced stage  (P < 0.01), negative  result 
previous year (P < 0.01),  and symptom-negative  (P < 
0.01) participants than in each counterpart, respectively. 
The ratio of female (22/35; 62.9%) patients in Negative 
advanced CRCs  tended  to be high compared with  that 
(40/83; 48.2%)  in First  advanced CRCs (P = 0.145). 
Overall, 22  (62.9%) of 35 Negative advanced CRCs 
and 28 (33.7%) of 83 First advanced CRCs were located 
in  the  right-sided colon, and  the  rate was  significantly 
higher in Negative advanced CRCs (P < 0.01). In addi-
tion, the frequency of female patients was significantly 
higher  in  right-sided Negative advanced CRCs than in 




it will be necessary  to  introduce a  screening program 
that is highly sensitive to right-sided CRC.
Key words  colorectal cancer;  fecal  immunochemical 
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Colorectal cancer (CRC) is one of the leading causes of 
cancer-related deaths in the world.1 Survival is strongly 
related to tumor stage at the time of diagnosis.2, 3 CRC 
deaths in Japan continue to increase, and in 2017, they 
were  second after  lung cancer. The number of cases 
of CRC is increasing year by year for both men and 
women, and the number of cases in 2014 was the high-
est.4 Population-based CRC screening programs enable 
detection of CRC at an earlier stage. Screening with fe-
cal occult blood tests (FOBTs) has been shown to reduce 
CRC-related mortality.5–7 According to the Guidelines 
for Colon Cancer Screening  (2005) based on  the ef-
ficacy assessment in Japan,8 screening with the guaiac-
based fecal occult blood test (gFOBT) has been shown 
to reduce CRC-related mortality  in  three  randomized, 




In  Japan, CRC screening programs are based on 
the fecal immunochemical test (FIT), which does not re-
quire dietary restrictions. This strategy has consistently 
demonstrated both high sensitivity for detecting ad-
vanced adenoma and invasive CRC and good adherence 
by  the  target population,9–11 since FITs have a better 
diagnostic accuracy than gFOBTs.12 Despite a lack of 
randomized  trials,  the available evidence  suggests  that 
















© 2020 Tottori University Medical Press
These cancer cases partially consist of interval cancers: 
cancer cases detected after a negative screening exami-
nation and before the date of the next recommended 
screening.20 So far, most studies have reported interval 
cancers in programs using gFOBT,  showing high 
proportions of  interval cancers.  In  such programs,  the 
proportion of interval cancer cases ranged from 48% to 
55%.6, 7, 21, 22 Recently, van der Vlugt et  al.23 reported 
low proportions of  interval cancers  (23%) using  the 
FIT. These studies have shown better survival rates for 
screen-detected cancers than for interval cancers.24
Since not all CRCs are detected at an early stage in 
FOBT screening, we see cases that are found at an ad-
vanced CRC stage after a negative screening result the 
previous year (Negative advanced CRC). In this study, 
the characteristics of Negative advanced CRC in a FIT 



















tion. Thus,  the positive  threshold  for hemoglobin was 
unclear. For all  screening  rounds combined,  the FIT 
positivity  rate was 10.0%, and adherence  to post-FIT 
colonoscopy was 76.9%.
Definitions




not had a FIT  screening history for more  than 3 years 
was defined as First  advanced CRC.  In Negative ad-
vanced CRC cases, those who had a false-positive result 
on a previous FIT but negative colonoscopy results were 
not included. The effects of sex, age at diagnosis, tumor 
location, and presence or absence of  symptoms were 




included as the right-sided colon in the analysis. Tumor 




Continuous variables are expressed as means ± standard 
deviation. The χ2 test or was used to compare categori-





Approval was obtained  from  the  Institutional Review 
Board  of Tottori University  (No.1511A079),  and 
informed consent  requirements were waived  for  this 
study.
RESULTS
Characteristics of screening-detected CRC
The clinicopathological characteristics of screening-
detected CRC are shown in Table 1. A total 109,639 par-










the other hand,  the  frequency of early  stage CRC was 
56.6%  in  the  left-sided colon and 41.7%  in  the  right-
sided colon. The difference between the left-sided colon 
and  the  right-sided colon was significant. Moreover, 
the rate of right-sided CRCs was significantly higher in 
female (P < 0.01), negative  result  the previous year  (P 




Screening history and stage of CRC




Features of FIT-detected advanced colorectal cancer





Characteristics of Negative advanced CRC (Table 3)
Of the detected CRCs,  35  (10.3%) were Negative 
advanced CRCs,  and 83  (24.5%) were First  advanced 
CRCs. The average age of Negative advanced CRC 
and First advanced CRC participants was 71.6 ± 8.03 
and 70.7 ± 8.72 years, respectively. The ratio of female 
(22/35; 62.9%) participants in Negative advanced CRCs 
was higher  than  that  (40/83; 48.2%)  in First  advanced 
CRCs, but it was not significantly different (P = 0.145). 
The frequency of right-sided location was significantly 
higher  in Negative advanced CRC than in First ad-
vanced CRC (P < 0.01).  In addition,  the  frequency of 
female participants was  significantly higher  in  right-
sided Negative advanced CRC than in right-sided First 








The effectiveness of CRC screening by gFOBT has 
been demonstrated by several RCTs.5–7 However, we 
see not only interval cancers,20 but also advanced CRCs 
(Negative advanced CRCs) detected by FIT screening 





right-sided  location and  female  sex,  similar  to  interval 
cancer.
FIT is one of the most commonly used CRC 




Right-sided (n = 127) Left-sided (n = 212)
Age at diagnosis (years) 71.5 ± 8.97 72.5 ± 9.27 70.9 ± 8.77 0.063
Sex, n (%)
 Male 175 44 (34.6) 131 (61.8)
< 0.01
 Female 164 83 (65.4) 81 (38.2)
Stage, n (%)
 Early 173 (51.0) 53 (41.7) 120 (56.6)
< 0.01
 Advanced 166 (49.0) 74 (58.3) 92 (43.4)
Screening history, n (%)
 First time 138 (40.7) 39 (30.7) 99 (46.7)
< 0.01
  Negative result previous year 102 (30.1) 54 (42.5) 48 (22.6)
 Other 99 (29.2) 34 (26.8) 65 (30.7)
Symptoms, n (%)
 (+) 112 (33.0) 30 (23.6) 82 (38.7)
< 0.01
  (–) 227 (67.0) 97 (76.4) 130 (61.3)





Screening-detected CRC, n 339 173 166
Screening history, n (%)
 First time 138 (40.7) 55 (31.8) 83 (50.0)
< 0.01
  Negative result previous year 102 (30.1) 67 (38.7) 35 (21.1)
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screening methods worldwide;  it  is moderately  sensi-
tive, noninvasive  for  the detection of neoplasia,  and 
has higher adherence rates compared to gFOBT. The 
greater adherence  to  screening with FIT may be the 
result of fewer dietary restrictions, easier sample collec-
tion, and  the  requirement  for  fewer  samples compared 
to gFOBT.9–12  In  the present  study, most FIT-detected 
CRCs were  located  in  the  left-sided colon, and FIT-
detected CRCs in the right-sided colon were frequent in 
female and advanced stage participants,  in agreement 
with previous reports.23, 26 In the screen-detected CRCs, 
cases with  symptoms were  located  less  frequently  in 
the right-sided colon than in the left-sided colon, where 
symptoms easily appear.27, 28
Fig. 1.  Anatomical locations of Negative advanced CRC (A) and First advanced CRC (B).
The frequency of female participants was significantly higher in right-sided Negative advanced CRC than in right-sided First advanced 
CRC (P = 0.03). A/C, Ascending Colon; D/C, Descending Colon; S/C, Sigmoid Colon; T/C, Transverse Colon.
Table 3. Characteristics of Negative and First advanced colorectal cancers
Screening history of advanced CRC
P-valueNegative advanced CRC 
(n = 35)
First advanced CRC 
(n =  83)
Age at diagnosis (years) 71.6 ± 8.03 70.7 ± 8.72 0.289
Sex, n (%)
 Male 13 (37.1) 43 (51.8)
0.145
 Female 22 (62.9) 40 (48.2)
Tumor location, n (%)
 Right-sided 22 (62.9) 28 (33.7)
< 0.01
  Left-sided 13 (37.1) 55 (66.3)
Symptoms, n (%)
 (+) 6 (17.1) 41 (49.4)
< 0.01
  (–) 29 (82.9) 42 (50.6)
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According  to  a 2015 nationwide  summary of 
gastrointestinal  cancer  screening  in  the  Japanese 
Society of Gastroenterological Cancer Screening,29 the 
percentage of CRCs found in first-time CRC screening 
was 36.7%.29  In  this  survey, 40.7% of CRCs found by 
CRC screening were first-time cases. The percentage of 
first-time cases was almost the same as in the national 
survey. The rate of advanced CRC detected by FIT 
screening was higher  in first-time cases  than  in cases 
with a negative screening result the previous year. Thus, 
the CRC cases found on first-time CRC screening tend 
to be more advanced than the CRC cases found in sec-
ond and subsequent screenings.
Several studies have reported that the FIT is less 
accurate in detecting right-sided than left-sided colorec-
tal neoplasia.26, 30, 31 With  regard  to cancer  location, 
lower FIT efficacy in the right colon may result from 
lesions  that grow more  rapidly and  that bleed  less due 
to phenotypic characteristics or weaker mechanical 
triggers. A longer transit time also may lead to degrada-
tion of hemoglobin,  resulting  in a negative  result on 
the FIT. Therefore,  the cancer  location  (right-sided vs. 
left-sided) might affect FIT sensitivity.26, 30–33 In the 
present study, the frequency of right-sided location was 
significantly higher in Negative advanced CRC than in 
First advanced CRC, indicating that FIT is not accurate 
enough to detect advanced CRC in the right-sided co-
lon. Overall, these data are in agreement with previous 
studies that found a lower FIT accuracy for right-sided 
versus left-side advanced neoplasia.23, 26, 30–33
Previous  studies have shown  that  interval cancer 
has a high  incidence  in  female participants,21, 34–36 but 
recently it has been reported that there is no differ-
ence.22, 35, 37  In  the present  study, Negative advanced 
CRC  had  a  higher  incidence  in women  than men 
(62.9% vs 37.1%), yet this difference was not significant. 
However,  in  the right-sided colon,  the rate of Negative 
advanced CRC was  significantly higher  in  female 
participants.




of colonoscopy,  such as  reducing  inadequate bowel 
preparation and  the operator’s adenoma detection  rate, 
is considered important. The number of deaths from 
CRC  continues  to grow  in  Japan and decrease  in  the 
USA. One of the reasons for the decrease in colon can-
cer deaths in the United States may be that about 60% 
of people undergo colonoscopy once every 10 years.39 
Moreover, a recent study revealed  that net survival for 
right-sided colon cancer was  significantly  lower  than 
that  for  left-sided disease  in a  Japanese population.40 
Since a CRC right-sided shift is seen in persons older 
than 60 years,41, 42 colonoscopy might supplement FIT 
to enhance detection of right-sided lesions. A random-
ized, controlled trial to verify the effect of colon cancer 
screening by total colonoscopy has been carried out in 
Spain43 and the Nordic countries.44






the same category.45 Second,  the  screening history 
of detected CRC  cases, but not all participants, was 
confirmed.
The  results of  the present  study showed  that  the 
characteristics of Negative advanced CRC were similar 
to  those of  interval cancer and were  related  to  tumor 
location and sex, suggesting the value of integrating FIT 
programs with colonoscopy. Future studies may address 
a screening method that is highly sensitive to right-sided 
CRC.
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